Influence of Emulsion Droplet Surface Charge on Indomethacin Ocular Tissue Distribution

The aim of this study was to compare the corneal penetration of indomethacin from Indocollyre® [a marketed hydro-poly(ethylene glycol) (PEG) ocular solution] to that of a negatively and a positively charged submicron emulsion. Male albino rabbits were separated randomly into three groups and each group (N = 15) was treated with either one drop of radiolabeled 0.1% Indocollyre, or 0.1% indomethacin positively or negatively charged submicron emulsion, respectively. The rabbits were sacrificed at selected time points and the eyes were enucleated. The eyes were dissected into the different tissues: cornea, conjunctiva, aqueous humor, iris, lens, vitreous, sclera, and retina. The samples were weighed before radioactivity counting. Regardless of the preparation instilled, the highest concentration of indomethacin was achieved in the cornea followed by conjunctiva, sclera retina, and aqueous humor. However, the positively charged emulsion provided significantly higher drug levels than the control solution and negatively charged emulsion only in the aqueous humor and sclera–retina. Furthermore, the spreading coefficient of the positively charged emulsion on cornea is four times higher than that of the negatively charged emulsion. It was therefore deduced that the positively charged submicron emulsions have better wettability properties on the cornea compared to either saline or the negatively charged emulsion. The positive charge may prolong the residence time of the drop on the epithelial layer of the cornea and thus enable better drug penetration through the cornea to the internal tissues of the eye, as confirmed by the animal studies.

[1]  S. Benita,et al.  Evaluation of a positively charged submicron emulsion of piroxicam on the rabbit corneum healing process following alkali burn. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[2]  M. Prausnitz,et al.  Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. , 1998, Journal of pharmaceutical sciences.

[3]  S. Benita,et al.  Ex-vivo permeation study of indomethacin from a submicron emulsion through albino rabbit cornea , 1997 .

[4]  M. Alonso,et al.  Improved Ocular Bioavailability of Indomethacin by Novel Ocular Drug Carriers , 1996, The Journal of pharmacy and pharmacology.

[5]  I. Ginsburg,et al.  Prevention of oxidative damage in fibroblast cell cultures and rat skin by positively-charged submicron emulsion of α-tocopherol , 1996 .

[6]  J. Lang Ocular drug delivery conventional ocular formulations , 1995 .

[7]  S. Benita,et al.  Physicochemical Characterization and Acute Toxicity Evaluation of a Positively‐charged Submicron Emulsion Vehicle , 1994, The Journal of pharmacy and pharmacology.

[8]  P. Ellis,et al.  Intraocular diclofenac and flurbiprofen concentrations in human aqueous humor following topical application. , 1994, Journal of ocular pharmacology.

[9]  S. Benita,et al.  Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization. , 1993, Journal of pharmaceutical sciences.

[10]  S. Benita,et al.  Positively charged submicron emulsions — a new type of colloidal drug carrier , 1993 .

[11]  U. Müller-Breitenkamp,et al.  [Ocular side effects of drugs]. , 1992, Laryngo- rhino- otologie.

[12]  S. Zhang,et al.  Inhibitory effect of tetrandrine on lens proteins-induced ocular inflammation in rabbits. , 1992, Journal of ocular pharmacology.

[13]  J. Tiffany Measurement of wettability of the corneal epithelium , 1990, Acta ophthalmologica.

[14]  Y. Rojanasakul,et al.  Transport mechanisms of the cornea: characterization of barrier permselectivity , 1989 .

[15]  D. Meisner,et al.  Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropine , 1989 .

[16]  F. Jané,et al.  Toxic coma induced by anticholinergic eye drops. , 1987, British medical journal.

[17]  F. Fraunfelder,et al.  Systemic side effects from ophthalmic timolol and their prevention. , 1987, Journal of ocular pharmacology.

[18]  V. H. Lee,et al.  Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: implications in the design of strategies to maximize the ratio of ocular to systemic absorption. , 1987, Journal of ocular pharmacology.

[19]  R. Schoenwald,et al.  Systemic absorption and cardiovascular effects of phenylephrine eyedrops. , 1985, American journal of ophthalmology.

[20]  R. Huupponen,et al.  Systemic absorption of topically applied ocular timolol. , 1985, Journal of ocular pharmacology.

[21]  E. Palmer,et al.  Plasma timolol in glaucoma patients. , 1984, Ophthalmology.

[22]  D. Sanders,et al.  Breakdown and reestablishment of blood-aqueous barrier with implant surgery. , 1982, Archives of ophthalmology.

[23]  R. Desnick,et al.  Enzyme therapy. VI: Comparative in vivo fates and effects on lysosomal integrity of enzyme entrapped in negatively and positively charged liposomes. , 1977, Biochimica et biophysica acta.

[24]  M. Mochizuki,et al.  Topical indomethacin in intracapsular extraction of senile cataract , 1977 .

[25]  G. Gregoriadis,et al.  Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications. , 1974, European journal of biochemistry.

[26]  G. Gregoriadis,et al.  Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats. , 1972, The Biochemical journal.

[27]  J. Koliopoulos,et al.  Ocular side effects of indomethacin. , 1972, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[28]  G. Willetts Ocular side-effects of drugs. , 1969, The British journal of ophthalmology.